Coherus Biosciences reported $550.91M in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acadia Pharmaceuticals ACAD:US USD 602.49M 10.28M
Aerie Pharmaceuticals AERI:US USD 375.59M 9.75M
Akebia Therapeutics AKBA:US USD 435.89M 85.91M
Alnylam Pharmaceuticals ALNY:US USD 3.54B 204.84M
Amarin AMRN:US USD 908.3M 64.93M
Amgen AMGN:US USD 63.7B 4.41B
Baxter International BAX:US USD 27.97B 3.87B
Biogen BIIB:US USD 24.85B 227.2M
Biomarin Pharmaceutical BMRN:US USD 6.26B 118.2M
Bluebird Bio BLUE:US USD 520.1M 53.49M
Bristol Myers Squibb BMY:US USD 98.2B 2.16B
Coherus Biosciences CHRS:US USD 550.91M 4.9M
Eli Lilly And LLY:US USD 47.46B 397.9M
Endo International Ordinary Shares ENDP:US USD 6.01B 355.8M
Fujifilm 4901:JP JPY 4.29T 39.71B
Gilead Sciences GILD:US USD 62.56B 313M
Horizon Pharma HZNP:US USD 9.03B 174.39M
Ironwood Pharmaceuticals IRWD:US USD 1.04B 64.65M
Myriad Genetics MYGN:US USD 1.21B 1.8M
Pacira Pharmaceuticals PCRX:US USD 1.73B 377K
Perrigo Ordinary Shares PRGO:US USD 10.68B 242.1M
Ptc Therapeutics PTCT:US USD 1.58B 227.66M
Regeneron Pharmaceuticals REGN:US USD 27.68B 472M
Revance Therapeutics RVNC:US USD 711.59M 149.71M
Sarepta Therapeutics SRPT:US USD 3.16B 159.3M
Teva Pharmaceutical TEVA:IT USD 44.25B 1.68B
Vertex Pharmaceuticals VRTX:US USD 16.71B 1.12B
Xencor XNCR:US USD 835.27M 16.06M
Zoetis ZTS:US USD 13.67B 96M